Vocodia Holdings Corp. Announces Engagement of Alpine Securities Corporation as Investment Banker
BOCA RATON, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp. (OTC: VHAI) ('Vocodia'), a leader in AI software development focusing on practical AI applications, is pleased to announce the engagement of Alpine Securities Corporation ('Alpine') as its new investment banker. This strategic partnership aims to enhance Vocodia's financial strategies and support its continued growth in the AI industry.
Alpine Securities Corporation is a broker-dealer and boutique investment firm known for its expertise in providing tailored financial solutions to emerging companies. Their commitment to understanding the unique needs of their clients aligns with Vocodia's innovative approach to AI technology
Brian Podolak, CEO of Vocodia, commented on the engagement: 'Partnering with Alpine Securities Corporation represents a significant step forward in our mission to revolutionize the AI landscape. Their deep industry knowledge and personalized approach to investment banking will be invaluable as we continue to expand our offerings and reach new markets.'
This engagement underscores Vocodia's commitment to leveraging strategic partnerships to drive growth and innovation in the AI sector. The company looks forward to a fruitful collaboration with Alpine Securities Corporation
About Vocodia Holdings Corp.
Vocodia is an AI software company that develops practical AI solutions, making them easily accessible for businesses through cloud-based platforms. These solutions are cost-effective and scalable to enterprise levels. Vocodia specializes in conversational AI, providing scalable enterprise-level AI sales and customer service solutions. Their Digital Intelligent Sales Agents (DISAs) are designed to sound and feel human, performing tasks that require human-like conversation, thereby reducing labor costs and enhancing communication effectiveness. For more information, please visit: http://www.vocodia.com
About Alpine Securities Corporation
Alpine Securities Corporation is a broker-dealer and boutique investment firm offering a range of financial services, including investment banking, brokerage, and advisory services. With a focus on personalized client solutions, Alpine is committed to supporting the growth and success of emerging companies across various industries.
Forward-Looking Statements
This release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: 'anticipate,' 'intend,' 'plan,' 'believe,' 'project,' 'estimate,' 'expect,' strategy,' 'future,' 'likely,' 'may,', 'should,' 'will' and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the risks and uncertainties more fully in the section captioned 'Risk Factors' in the Company's Registration Statement on Form S-1 related to the public offering (SEC File No. File No. 333-269489) and other reports we file with the SEC. As a result of these matters, changes in facts, assumptions not being realized or other circumstances, our actual results may differ materially from the expected results discussed in the forward-looking statements contained in this press release. Forward-looking statements contained in this announcement are made as of this date and undertake no duty to update such information except as required under applicable law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
18 minutes ago
- Business Insider
Ord Minnett Remains a Buy on Telstra Corporation Limited (TTRAF)
Ord Minnett analyst maintained a Buy rating on Telstra Corporation Limited (TTRAF – Research Report) today and set a price target of A$5.00. The company's shares closed last Thursday at $3.15. Confident Investing Starts Here: In addition to Ord Minnett, Telstra Corporation Limited also received a Buy from Morgan Stanley's Andrew McLeod in a report issued on May 28. However, on the same day, UBS downgraded Telstra Corporation Limited (Other OTC: TTRAF) to a Hold. The company has a one-year high of $3.45 and a one-year low of $2.19. Currently, Telstra Corporation Limited has an average volume of 29.92K. Based on the recent corporate insider activity of 6 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of TTRAF in relation to earlier this year.
Yahoo
2 hours ago
- Yahoo
SOMA GOLD INTERSECTS VENUS GAP VEIN AT DEPTH WITH 7.5 g/t Au OVER 6.0 m, EXTENDING ZONE BY 135 m
Highlights include the following drill intercepts: RVICDDH-24-032 1.7 m at 9.2g/t Au incl. 0.6 m at 18.8g/t Au RVICDDH-24-034 2.1 m at 11.9g/t Au incl. 0.65 m at 32.5g/t Au RVICDDH-24-040 6.0 m at 7.5g/t Au incl. 0.65 m at 9.3g/t Au and 0.5m at 67.8g/t Au VANCOUVER, BC, June 11, 2025 /CNW/ - Soma Gold Corp. (TSXV: SOMA) (WKN: A2P4DU) (OTC: SMAGF) (the "Company" or "Soma") is pleased to announce ongoing drill results targeting the "Venus Gap" zone of the Cordero Mine on the Bagre Project in central Colombia (Figure 1). Twelve diamond drill holes, totaling 2,848 meters of underground drilling, were designed to test the dip extent of the Venus Gap Zone (see Figures 2 and 3). The drilling results outlined in this press release extend the dip of the vein by approximately 135 meters downdip. The Cordero Deposit is hosted in the El Carmen Stock and consists of coarse-grained tonalite, diorite, and gabbroic phases. The quartz veins form as laminated fault-fill veins within a sinistral brittle-ductile shear zone. They are interpreted as conjugate shears within a steeply dipping, north-striking regional shear zone. The controlling shear zone also hosts the Los Mangos Deposit, located 2.8 kilometres to the north. The quartz veins in the Cordero Deposit form a series of en echelon segments that consistently step to the right along strike. The veins have been repeatedly reactivated and exhibit three distinct phases of development: early barren quartz veins, sphalerite + galena + pyrite + gold mineralization controlled by microfractures, and brittle fracturing along the margins of the veins filled with quartz + pyrite + tellurides + gold. Gold mineralization occurs during the latter two phases of vein development. The final stage of brittle fracturing and micro-breccia is commonly associated with 'bonanza' gold grades. Subsequently, the veins are crosscut by aphanitic mafic dykes and numerous brittle faults. The brittle faults are generally dextral and offset the quartz veins from <1.0m to 10s of metres. The late brittle faults commonly dismember the mineralized veins into short strike-length segments, the continuity of which is difficult to discern from drill data. The Cordero Deposit is informally divided into five main zones: Athenas, Cordero, Venus, Venus Gap, and Victoria Ramp zones (Figure 2). Table 1: Composited assay results from the lower Venus Gap ZoneTable 1 Composited assay results from Lower Venus Gap Zone Hole ID From (m) To (m) Length (m) Au (g/t) Ag (g/t) RVICDDH-24-030 158.8 160.3 1.5 6.4 17.7 including 159.7 160.3 0.6 15.9 42.9 RVICDDH-24-031 141.5 143.7 2.2 6.7 8.4 including 141.5 142.3 0.8 7.3 6.9 including 142.3 142.7 0.4 14.9 23.0 RVICDDH-25-032 184 185.65 1.65 9.2 15.7 including 184 184.6 0.6 18.8 30.3 RVICDDH-25-034 154.45 156.55 2.1 11.9 31.8 including 154.45 155.1 0.65 32.5 92.1 RVICDDH-25-035 193 194.7 1.7 3.6 4.7 including 194 194.7 0.7 6.5 7.9 RVICDDH-25-036 204.1 205.1 1 1.4 1.9 RVICDDH-25-037 no significant results RVICDDH-25-038 no significant results RVICDDH-25-039 138.9 140.2 1.3 0.5 1.3 RVICDDH-25-040 176.6 182.6 6 7.5 10.2 including 177.25 177.9 0.65 9.3 21.4 including 180.05 180.55 0.5 67.8 39.7 RVICDDH-25-041 no significant results RVICDDH-25-042 169.4 172 2.6 6.7 9.9 including 171.4 172 0.6 19.5 33.8 Note: all intervals are presented as drilled width. True width is approximately 80%-90% of the drill interval. Soma's Vice President of Exploration, Chris Buchanan, stated, "Drilling in the Venus Gap Zone continues to return the broadest, high-grade intervals in the mine. Extending this zone down dip adds resources to the mine plan and supports development of deeper levels of the Venus and Venus Gap veins." Table 1 presents the composited assay results from twelve drill holes at the Venus Gap Zone. Assays in the drilling range from below detection to a maximum grade of 67.8 g/t Au. The drilling currently covers approximately 150 m of strike length between the southern-most drill intercept (RVICDDH-25-035) and the northern-most intercept (RVICDDH-25-040). RVICDDH-25-036 extends the known dip of the vein system 135m down dip from the 0770 level, the current mining operations. Like other parts of the Venus Gap Zone, wider zones of mineralized stockwork in the footwall of the principal gold-bearing quartz veins and in enclaves of wall rock between anastomosing vein segments were intersected. RIVICDDH-25-040 intersected the widest interval of gold mineralization in the lower Venus Gap with a total width of 6.0 m and an average grade of 7.5 g/t gold (Plate 1). Three of the drill holes intersected quartz veins but did not return significant gold assays (Table 1). This is attributed to the nuggety nature of the gold distribution observed across the Cordero Deposit. A long section of the drill intercepts is presented in Figure 3. The high-grade intercepts delineate multiple segments of the vein system that are separated by cross-cutting faults and late mafic dykes. Selected highlights from the 2024 drill campaign on the upper Venus Gap vein are presented in Table 2 (see news release dated November 12, 2024). Underground drilling is ongoing in this area to determine the strike and dip extents of the lower Venus Gap quartz veins. The vein segments are located proximal to existing mine workings in the Victoria Ramp and Venus Vein areas. Access to the lower Venus Gap is planned from the Victoria Ramp workings and is expected to intersect the veins in Q4 2025. Table 2: Selected highlight intersections from the upperVenus Gap vein (see press release dated November 12, 2024)Hole ID From (m) To (m) Length (m) Au (g/t) BAZUDDH-24-018 52.45 57.65 5.2 16.1 includes 52.45 53.25 0.8 94.3 includes 55.3 55.65 0.35 4.8 RVICDDH-24-018 71.6 73.1 1.5 6.6 includes 71.6 72.6 1 8.8 and 134 135 1 12.5 and 138.4 140.8 2.4 5.4 includes 139.4 140.1 1.4 8.5 and 144.55 145.55 1 2.7 RVICDDH-24-021 46 47 1 3.3 and 76.5 77.5 1 13.7 includes 77.1 77.5 0.4 34.3 and 81.5 82.5 1 11.2 includes 82.1 82.5 0.4 27.6 and 128.2 132.7 4.5 9.3 includes 128.8 129.4 0.6 8.3 includes 130.95 131.8 0.85 27.8 RVICDDH-24-024 71.6 74.6 3 8.9 includes 71.6 72.45 0.85 10 includes 74.2 74.6 0.4 45.1 and 140.4 147.95 7.55 13.9 includes 140.4 141.7 1.3 24.7 includes 146.5 147.95 1.45 48.6 and 151.5 153.3 1.8 4.5 includes 152.3 153.3 1 6.4 VICDDH-23-006 100.1 101.8 1.7 4.1 and 151.15 154.65 3.5 10.7 includes 151.15 151.8 0.65 9 includes 151.8 152.8 1 21.3 includes 152.8 153.65 0.85 10.7 and 158.4 161.2 2.8 1.7Note: Intervals are composited to a 1 m minimum stope width for conventional mining. The drillholes are targeted to intersect the vein orientation as perpendicular as possible. The true width is approximately 70% to 90% of the drilled width. In addition to supporting mining operations at Cordero Mine, Soma's exploration team continues to evaluate numerous small-scale mines near Machuca. Drilling is ongoing at the Colossa and Colossa 2 informal mines (Figure 4). Three high-priority Au anomalies close to informal mines were identified in the regional soil survey. Additionally, the copper anomaly identified on the soil grid is the focus of infill soil sampling and geological mapping. These targets are scheduled for detailed geological mapping and drilling in the second half of 2025. Soma also continues to work with the local communities on the Machuca Property as part of its ongoing ESG program. The Otú fault system ("Otú Fault") extends for over 100 km, from Aris's Segovia-Remedios mines (TSX:ARIS) in the south to Nechi in the north, where it is buried beneath younger sedimentary overlap sequences. Soma's property holdings now cover more than 56 km of this regional structure. High-grade gold mineralization occurs along the entire strike length of the Otú Fault. The high-grade gold occurs in brittle-ductile to brittle quartz veins formed during the later stages of deformation along the Otú Fault. Across the district, the quartz veins typically display orientation patterns that suggest the veins form in conjugate faults associated with brittle faulting on the Otú Fault. Notable deposits along this trend include Segovia-Remedios, La Aurora, El Limon, Le Ye, Los Mangos, and Cordero. The Machuca Property is located along a critical segment of this regional fault structure and displays multiple indications of high-grade gold mineralization. QA/QC Statement Soma follows a comprehensive QA/QC program to ensure the reliability of assay data collected from its exploration programs. All samples are sawn or split in half, with one half being returned to the core box for storage. The second half-core is placed in a labelled plastic bag with a tag, document, and sealed for shipment. Batches of samples are shipped to Actlabs Colombia SAS (Actlabs) in Rio Negro with security tags and documented chain of custody. Pulps of each sample are prepared in Rio Negro. Pulp samples are then shipped to Actlabs Canada for multi-element analysis. All samples are analyzed using package 1E3, an ICP-MS analysis that provides the concentration of 51 elements. Fire assay analysis for gold and Silver is completed by Actlabs in Rio Negro. Thirty-gram aliquots of each sample are analyzed for gold using a standard fire assay with an atomic absorption finish, package 1A2. Overlimit samples are subjected to an additional fire assay with a gravimetric finish, package 1A3-30, to determine the gold concentration. A comprehensive QA/QC program has been implemented to monitor the reliability of assay data collected during exploration programs. The program includes the regular insertion of certified blanks, duplicates, and certified OREAS standards. Assays of the QA/QC samples are automatically compared to the certified value and standard deviations in the database. Qualified Person Statement Mr. Chris Buchanan, is Soma's Vice-President of Exploration and a Qualified Person as defined by National Instrument 43-101. Mr. Buchanan has reviewed the technical information disclosed in this press release. ABOUT SOMA GOLD Soma Gold Corp. (TSXV: SOMA) is a mining company focused on gold production and exploration. The Company owns two adjacent mining properties in Antioquia, Colombia with a combined milling capacity of 675 tpd. (Permitted for 1,400 tpd). The El Bagre Mill is currently operating and producing. Internally generated funds are being used to finance a regional exploration program. With a solid commitment to sustainability and community engagement, Soma Gold Corp. is dedicated to achieving excellence in all aspects of its operations. The Company also owns an exploration property near Tucuma, Para State, Brazil that is currently under option to Ero Copper Corp. On behalf of the Board of Directors "Geoff Hampson"Chief Executive Officer and Chairman Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. All statements, analysis and other information contained in this press release about anticipated future events or results constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event or result "may", "will", "should", "could" or "might" occur or be achieved and other similar expressions. Forward-looking statements are subject to business and economic risks and uncertainties and other factors that could cause actual results of operations to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements. SOURCE Soma Gold Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hamilton Spectator
3 hours ago
- Hamilton Spectator
Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients
VANCOUVER, BC, June 11, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') is pleased to announce that it has released its latest version of the Medical Education Suite (MES). The University of Minnesota Medical School has successfully completed a live deployment of AI's new Medical Education Suite (MES), an AI-powered clinical skills assessment platform designed to support medical schools in delivering scalable, rigorous, and cost-effective Objective Structured Clinical Examinations (OSCEs). The deployment, conducted with over 240 third-year medical students, marked the first large-scale implementation of computer-simulated patient cases developed through the Global Library of Medicine (GLM), a clinician-built medical knowledge engine. The exams ran with complete technical reliability during deployment, as well as integrating seamlessly into the school's existing OSCE workflow. 'Our goal is to support medical schools by applying our clinical experience and AI expertise to real educational challenges.' stated Dr. Kevin Peterson, Founder and Chief Medical Officer of AI. 'The Medical Education Suite reflects years of development in diagnostic reasoning and knowledge engineering. By introducing structured, AI-simulated patients alongside live simulated patients, and offering objective real-time scoring, we're helping students build stronger clinical skills in the classroom and giving educators the trusted healthcare education software needed to teach and assess clinical content and behavioral approaches to complex clinical problems with confidence.' The MES is a scalable platform designed to reduce administrative and faculty time, improve objectivity, increase evaluation consistency, and provide a robust digital infrastructure to support both live and AI-simulated formats. The focus of the platform is to help enhance the clinical skills of our next generation of healthcare professionals. By incorporating curated AI-generated cases and the supportive services provided by Treatment, the system enables: 'Partnering with AI gave us the opportunity to explore how clinically governed AI can strengthen the way we assess and support student learning. The MES allowed us to deliver a high-stakes OSCE at scale, while ensuring consistent, objective evaluation aligned with our academic standards. The MES represents a meaningful step forward in the evolution of medical education.' said Professor Claudio Violato, Assistant Dean, University of Minnesota Medical School. 'We look forward to sharing our findings.' The MES combines AI-simulated patients with automated feedback, helping faculty assess diagnostic and management reasoning, clinical prioritization, and documentation quality, all mapped to learning objectives. Early feedback suggests that the platform enhances the student learning experience and strengthens the reliability of OSCE results. Preliminary results of the accuracy and precision of the GLM as applied in the MES platform were presented at the AAMC's 2025 Group on Information Resources meeting. Prof. Violato, Dr. Peterson, and their respective teams are preparing further scientific publications detailing the methodology, deployment, and outcomes of the UMN program. AI is engaging with a wide variety of other schools, with the goal to extend the MES offering across North America, the UK, and to other international OSCE markets. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at: or contact . About University of Minnesota Medical School Founded in 1888, the University of Minnesota Medical School is one of the nation's largest, with three campuses in Minneapolis, Duluth, and St. Cloud. It enrolls first- and second-year students at Duluth and St. Cloud, and carries clinical training at the Twin Cities campus and affiliated hospitals. The school educates future physicians through MD, graduate, undergraduate, and continuing professional development programs, supported by over 3,000 faculty members and 20+ research centers and institutes. Its core mission is to improve health through exceptional education, compassionate patient care, and leading-edge biomedical research, particularly focusing on primary care, specialty medicine, rural communities, and American Indian/Alaska Native populations. The school is nationally recognized for its NIH-funded research (ranked #21 overall, #2 among public medical schools) and emphasizes interprofessional, community-based training while promoting equity and access across diverse populations. Learn more at: FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO – AI Inc. Email: Media inquiries: Sales: Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although AI believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
